Milena Y Gotra1, Scot K Hill1, Elliot S Gershon2, Carol A Tamminga3, Elena I Ivleva3, Godfrey D Pearlson4, Matcheri S Keshavan5, Brett A Clementz6, Jennifer E McDowell6, Peter F Buckley7, John A Sweeney8, Sarah K Keedy9. 1. Department of Psychology, Rosalind Franklin University, North Chicago, IL, United States. 2. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States. 3. Department of Psychiatry, UT-Southwestern Medical Center, Dallas, TX, United States. 4. Departments of Psychiatry and Neuroscience, Yale University School of Medicine, New Haven, CT, United States; Institute of Living, Hartford Hospital, Hartford, CT, United States. 5. Department of Psychiatry, Beth Israel Deaconness Medical Center and Harvard Medical School, Boston, MA, United States. 6. Department of Psychology and Neuroscience, University of Georgia, Athens, GA, United States. 7. School of Medicine, Virginia Commonwealth University, Richmond, VA, United States. 8. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, United States. 9. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States. Electronic address: skeedy@uchicago.edu.
Abstract
BACKGROUND: Deficits in inhibitory control on a Stop Signal Task (SST) were previously observed to be of similar magnitude across schizophrenia, schizoaffective, and bipolar disorder with psychosis, despite variation in general cognitive ability. Understanding different patterns of performance on the SST may elucidate different pathways to the impaired inhibitory control each group displayed. Comparing nonpsychotic bipolar disorder to the psychosis groups on SST may also expand our understanding of the shared neurobiology of this illness spectrum. METHODS: We tested schizophrenia (n = 220), schizoaffective (n = 216), bipolar disorder with (n = 192) and without psychosis (n = 67), and 280 healthy comparison participants with a SST and the Brief Assessment of Cognition in Schizophrenia (BACS), a measure of general cognitive ability. RESULTS: All patient groups had a similar degree of impaired inhibitory control over prepotent responses. However, bipolar groups differed from schizophrenia and schizoaffective groups in showing speeded responses and inhibition errors that were not accounted for by general cognitive ability. Schizophrenia and schizoaffective groups had a broader set of deficits on inhibition and greater general cognitive deficit, which fully accounted for the inhibition deficits. No differences were found between the clinically well-matched bipolar with and without psychosis groups, including for inhibitory control or general cognitive ability. CONCLUSIONS: We conclude that 1) while impaired inhibitory control on a SST is of similar magnitude across the schizo-bipolar spectrum, including nonpsychotic bipolar, different mechanisms may underlie the impairments, and 2) history of psychosis in bipolar disorder does not differentially impact inhibitory behavioral control or general cognitive abilities.
BACKGROUND: Deficits in inhibitory control on a Stop Signal Task (SST) were previously observed to be of similar magnitude across schizophrenia, schizoaffective, and bipolar disorder with psychosis, despite variation in general cognitive ability. Understanding different patterns of performance on the SST may elucidate different pathways to the impaired inhibitory control each group displayed. Comparing nonpsychotic bipolar disorder to the psychosis groups on SST may also expand our understanding of the shared neurobiology of this illness spectrum. METHODS: We tested schizophrenia (n = 220), schizoaffective (n = 216), bipolar disorder with (n = 192) and without psychosis (n = 67), and 280 healthy comparison participants with a SST and the Brief Assessment of Cognition in Schizophrenia (BACS), a measure of general cognitive ability. RESULTS: All patient groups had a similar degree of impaired inhibitory control over prepotent responses. However, bipolar groups differed from schizophrenia and schizoaffective groups in showing speeded responses and inhibition errors that were not accounted for by general cognitive ability. Schizophrenia and schizoaffective groups had a broader set of deficits on inhibition and greater general cognitive deficit, which fully accounted for the inhibition deficits. No differences were found between the clinically well-matched bipolar with and without psychosis groups, including for inhibitory control or general cognitive ability. CONCLUSIONS: We conclude that 1) while impaired inhibitory control on a SST is of similar magnitude across the schizo-bipolar spectrum, including nonpsychotic bipolar, different mechanisms may underlie the impairments, and 2) history of psychosis in bipolar disorder does not differentially impact inhibitory behavioral control or general cognitive abilities.
Authors: Brett A Clementz; John A Sweeney; Jordan P Hamm; Elena I Ivleva; Lauren E Ethridge; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga Journal: Am J Psychiatry Date: 2015-12-07 Impact factor: 18.112
Authors: Lauren E Ethridge; Melanie Soilleux; Paul A Nakonezny; James L Reilly; S Kristian Hill; Richard S E Keefe; Elliot S Gershon; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney Journal: Schizophr Res Date: 2014-09-26 Impact factor: 4.939
Authors: Sudhakar Selvaraj; Danilo Arnone; Dominic Job; Andrew Stanfield; Tom Fd Farrow; Allison C Nugent; Harald Scherk; Oliver Gruber; Xiaohua Chen; Perminder S Sachdev; Daniel P Dickstein; Gin S Malhi; Tae H Ha; Kyooseob Ha; Mary L Phillips; Andrew M McIntosh Journal: Bipolar Disord Date: 2012-03 Impact factor: 6.744
Authors: Cynthia Z Burton; Kelly A Ryan; Masoud Kamali; David F Marshall; Gloria Harrington; Melvin G McInnis; Ivy F Tso Journal: Bipolar Disord Date: 2017-08-23 Impact factor: 6.744
Authors: Matcheri S Keshavan; David W Morris; John A Sweeney; Godfrey Pearlson; Gunvant Thaker; Larry J Seidman; Shaun M Eack; Carol Tamminga Journal: Schizophr Res Date: 2011-10-12 Impact factor: 4.939
Authors: Guillermo Lahera; José Manuel Montes; Adolfo Benito; María Valdivia; Elena Medina; Isabel Mirapeix; Jerónimo Sáiz-Ruiz Journal: Psychiatry Res Date: 2008-11-08 Impact factor: 3.222
Authors: Margret S H Harris; James L Reilly; Michael E Thase; Matcheri S Keshavan; John A Sweeney Journal: Psychiatry Res Date: 2009-11-10 Impact factor: 3.222
Authors: David C Glahn; Carrie E Bearden; Marcela Barguil; Jennifer Barrett; Abraham Reichenberg; Charles L Bowden; Jair C Soares; Dawn I Velligan Journal: Biol Psychiatry Date: 2007-06-01 Impact factor: 13.382
Authors: Leah H Rubin; Jiaxu Han; Jennifer M Coughlin; S Kristian Hill; Jeffrey R Bishop; Carol A Tamminga; Brett A Clementz; Godfrey D Pearlson; Matcheri S Keshavan; Elliot S Gershon; Keri J Heilman; Stephen W Porges; John A Sweeney; Sarah Keedy Journal: Schizophr Res Date: 2021-12-07 Impact factor: 4.662
Authors: Brett A Clementz; David A Parker; Rebekah L Trotti; Jennifer E McDowell; Sarah K Keedy; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Elena I Ivleva; Ling-Yu Huang; S Kristian Hill; John A Sweeney; Olivia Thomas; Matthew Hudgens-Haney; Robert D Gibbons; Carol A Tamminga Journal: Schizophr Bull Date: 2022-01-21 Impact factor: 9.306